Therapeutic efficacy of telbivudine for treating chronic hepatitis B patients with elevated levels of serum soluble E-selectin

Zhang XueHua; Zhu ChuanWu; Luo XiangRong; Chai XiaoZhe

Issue 11

Nov. 2012

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2012 > 28(11): 839-840+844

PDF( 2055 KB)

Therapeutic efficacy of telbivudine for treating chronic hepatitis B patients with elevated levels of serum soluble E-selectin

Published Date: 2012-11-20

Abstract

Abstract

Objective To compare the levels of hepatitis B surface antigen (HBsAg) and serum soluble (s) E-selectin before and after telbivudine (LdT) treatment in patients with chronic hepatitis B (CHB) .Methods One-hundred-and-seven patients with CHB and 82 healthy controls were enrolled in the study.The levels of HBsAg and serum sE-selectin were measured by enzyme-linked immunosorbent assay (ELISA) before and after LdT treatment.The correlation between HBsAg and serum sE-selectin was analyzed by Pearson′s correlation analysis.Results The pre-treatment sE-selectin content of the CHB group was significantly higher than that of the healthy control group (P<0.01) .The levels of both HBsAg and sE-selectin were significantly reduced in the CHB group after treatment with LdT (P<0.01) .The correlation analysis showed that the HBsAg level was positively correlated with the content of sE-selectin (P<0.01) .Conclusion sLdT may inhibit HBV replication by decreasing the serum sE-selectin content, which may lead to an enhanced immune function.
- telbivudine,
- hepatitis B,
- chronic

FullText(HTML)

References(11)

References

[1]朱传武, 王海燕, 李明, 等.干扰素治疗慢性乙型肝炎与外周血树突状细胞表型的关系[J].中华肝脏病杂志, 2004, 12 (3) :51-52.

[2]祝先进, 宋艳芳, 曹颖平, 等.慢性乙型肝炎患者外周血趋化因子CXCL10和CXCL11的表达及意义[J].临床肝胆病杂志, 2011, 27 (8) :804-806.

[3]Wu S, Zhou X, Yang H, et al.Polymorphisms and plasma solublelevels of E-selectin in patients with chronichepatitis B virus infec-tion[J].Clin Chem Lab Med, 2009, 47 (2) :159-164.

[4]Yan MX, Mao HT, Liu Q, et al.Elevated levels of serum soluble E-selectin in patients with chronic hepatitis B:Correlation with Tlymphocyte subsets, NK cells and liver inflammation[J].HepatolRes, 2006, 35 (2) :111-117.

[5]罗生强.替比夫定治疗慢性乙型肝炎的新进展[J].中国新药杂志, 2008, 17 (8) :625-629.

[6]赵文莉, 王保春, 黄飞.替比夫定治疗乙型肝炎肝硬化患者48周临床观察[J].临床肝胆病杂志, 2011, 27 (8) :840-843.

[7] 中华医学会肝病学分会, 中华医学会感染学分会.慢性乙型肝炎防治指南 (2010年版) [J].临床肝胆病杂志, 2011, 27 (1) :I-XVI.

[8]吴小宁, 徐丹.拉米夫定对慢性乙型肝炎患者白细胞介素-6和肝纤维化指标的影响[J].中国现代医学杂志, 2011, 21 (22) :2780-2782.

[9]Liaw YF, Gane E, Leung N, et al.2-Year GLOBE trial results:telbivudine Is superior to lamivudine in patientswith chronic hepati-tis B[J].Gastroenterology, 2009, 136 (2) :486-495.

[10]Hou J, Yin YK, Xu D, et al.Telbivudine versus lamivudine inChinese patients with chronic hepatitis B:Results at 1 year of a ran-domized, double-blind trial[J].Hepatology, 2008, 47 (2) :447-454.

[11]蔡伟娟, 陈慧园, 程江.E-选择素在肝脏疾病中的研究进展[J].临床荟萃, 2011, 26 (13) :1192-1195.

Relative Articles

[1]	Li Na, Gou Wei, Cui WeiLi. Efficacy of telbivudine combined with adefovir dipivoxil and pegylated interferon combined with entecavir as antiviral therapy for chronic hepatitis B: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(9): 1714-1716. doi: 10.3969/j.issn.1001-5256.2016.09.015
[2]	Huang ShuiWen, Liu BaoRong, Chen MingSheng, Lin Chun, Zhou Rui, Yang HuiAn, Jiang XiaoYan, Pan Chen, Li DongLiang. Establishment of a predictive model for early virologic response in previously untreated chronic hepatitis B patients treated with telbivudine[J]. Journal of Clinical Hepatology, 2016, 32(7): 1287-1291. doi: 10.3969/j.issn.1001-5256.2016.07.014
[3]	Wang Fang, Quan ZuoHua, Yang XingKun, Kou JunFeng, Yun ShengHao, Cai GuoFang, Zhou XinRen. Influence of antiviral therapy with telbivudine on serum soluble complement receptor type 1 in patients with chronic hepatitis B or liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1118-1120. doi: 10.3969/j.issn.1001-5256.2016.06.019
[4]	Peng MeiJuan, Wang Wei, Yang XiaoFei, Hao ChunQiu, Bai XueFan, Jia ZhanSheng, Lian JianQi, Zhang Ye. Influence of pegylated interferonα- 2a versus telbivudine on renal function in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(4): 682-686. doi: 10.3969/j.issn.1001-5256.2016.04.014
[5]	Wang RongQi, Nan YueMin. Neutropenia caused by telbivudine in chronic hepatitis B patients: a report of one case[J]. Journal of Clinical Hepatology, 2015, 31(2): 273-274. doi: 10.3969/j.issn.1001-5256.2015.02.031
[6]	Li HuoYan, Yang ZhaoHui, Ma LiLi, Ma Long. Clinical efficacy of telbivudine and interferon in treatment of HBe Ag-positive chronic hepatitis B: a comparative study[J]. Journal of Clinical Hepatology, 2015, 31(4): 526-529. doi: 10.3969/j.issn.1001-5256.2015.04.012
[7]	Guo RuYi, Yu XuePing, Su ZhiJun, Lin ChengZu, Lin ZhiPeng, Lin Qi. Evaluation of telbivudine’s efficacy for treating HBeAg-positive chronic B hepatitis patients and identification of its predictive factors by logistic regression analysis[J]. Journal of Clinical Hepatology, 2013, 29(2): 97-100.
[8]	Dong XiaoPing. Therapeutic effect of telbivudine combined with Fuzheng Huayu tablets in treatment of liver fibrosis in chronic hepatitis B: a report of 60 cases[J]. Journal of Clinical Hepatology, 2013, 29(9): 689-691. doi: 10.3969/j.issn.1001-5256.2013.09.014
[9]	Jiang XiuNong, Fan LingYan, Li DeZhou, Wan Jiong, Ye JingJing. Clinical trial of telbivudine in the treatment of chronic hepatitis B in patients during the third trimester of pregnancy[J]. Journal of Clinical Hepatology, 2013, 29(2): 101-103.
[10]	Xie Rong, Jiang JianNing, Su MingHua, Liu ZhiHong, Zhong ShaoHua, He LiXia, Liang YanXiu, Hu JiaGuang, Huang XiaoHong, Guo WenWen, Fu WuDao, Zhu MeiQin, Wang BaoJian. Efficacy and safety of initial telbivudine treatment in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 422-424+427.
[11]	Zhao WenLi, Wang BaoChun, Huang Fei. Therapeutic effects of 48-week telbivudine treatment in patients with cirrhosis caused by HBV[J]. Journal of Clinical Hepatology, 2011, 27(8): 840-843.
[12]	Song LiWen, Zhao GuiMing, Cao WuKui, Lu ChengZhen. Meta analysis of the comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(9): 955-961.
[13]	Wang HaiYan, Wang Yu, Peng XiaoMing, Liu Ya. Recent advancement of telbivudine in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(12): 1320-1322+1326.
[14]	Zhan GuoQing, Tan HuaBing, Zhang WeiWei, Li RuGui, Xie XingRong, Hu Bo. The factors predicting the efficacy of telbivudine in the treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(6): 608-610.
[15]	Jin QingLong, Wang ZhongFeng, Yan HongQing, Niu JunQi. The study of the change in creatine kinase in patients with chronic hepatitis B during the antiviral treatment with Telbivudine and Lamivudine[J]. Journal of Clinical Hepatology, 2011, 27(2): 143-144+156.
[16]	Yao QinJiang, Ma WeiGuo. Therapeutic efficacy of telbivudine in hepatitis B e antigen positive chronic hepatitis B patients with high baseline alanine aminotransferase levels[J]. Journal of Clinical Hepatology, 2011, 27(6): 614-616.
[17]	Wu HangYuan, You DeHong. The efficacy of Telbivudine therapy on decompensated hepatitis B cirrhosis documentation[J]. Journal of Clinical Hepatology, 2010, 26(6): 605-607.
[18]	Zhang WeiWei, Yuan XueHua, Tan HuaBing, Zhan GuoQing, Li RuGui, Du WeiXing. Therapeutic Efficacy of telbivudine with phentolamine on patients with chronic severe hepatits B[J]. Journal of Clinical Hepatology, 2009, 25(6): 418-419.
[20]	Li Zhi, Yan HongMei, Xue FaXuan, Wang Tong, Liang Qun, Xu Huan, Li ZhangChun. Short-term clinical effect of telbivudine in the treatment chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(6): 420-421+426.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2817) PDF downloads(634)

Therapeutic efficacy of telbivudine for treating chronic hepatitis B patients with elevated levels of serum soluble E-selectin

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Therapeutic efficacy of telbivudine for treating chronic hepatitis B patients with elevated levels of serum soluble E-selectin

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content